Adedoyin Akinware

Papers

Total Citations

H-Index

About

Adedoyin Akinware is a leading voice at the intersection of artificial intelligence and pharmaceutical innovation, with a primary research focus on AI-driven drug discovery platforms. In their seminal 2025 work, "Leading artificial intelligence–driven drug discovery platforms: 2025 landscape and global outlook," Akinware provides a comprehensive analysis of the rapidly evolving ecosystem of AI technologies transforming the drug development pipeline. This highly cited paper (12 citations) maps the competitive landscape of major platforms, evaluating their capabilities in target identification, molecular design, and clinical trial optimization. Akinware’s contribution is particularly notable for offering a forward-looking, global perspective that helps researchers and industry stakeholders navigate the complex interplay between machine learning models, big data, and therapeutic discovery. By synthesizing technical advancements with strategic insights, Akinware has established themselves as a key commentator on how AI is reshaping the speed, cost, and success rates of bringing new drugs to market. Their work is essential reading for anyone seeking to understand the practical applications and future trajectory of AI in biomedicine.